Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending ...

If you suffered losses exceeding $100,000 in AstraZeneca between between February 23, 2022 and December 17, 2024 and would ...

SAN DIEGO, CA / ACCESSWIRE / January 9, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...

Shares of AstraZeneca PLC AZN rose 2.18% to £109.88 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.83% to 8,319.69.

Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both ...

The latest trading day saw Astrazeneca (AZN) settling at $66.58, representing a -0.09% change from its previous close.

AstraZeneca has been taking a wider role in Vietnam’s healthcare sector to help expand access to quality healthcare.

AZN's key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Fasenra are likely to drive sales. It has several candidates ...

AstraZeneca PLC (LON:AZN – Get Free Report) has been assigned an average rating of “Moderate Buy” from the nine analysts that ...

Johnson & Johnson’s combination of Rybrevant and Lazcluze has racked up an overall survival (OS) victory against ...

AstraZeneca continues to advance its ambition to revolutionise cancer care with pivotal data presented for lung, gastrointestinal (GI), and breast cancers at the recent ESMO Asia Congress 2024. With a ...